Abstract
Distant metastasis account for about 90 % of cancer associated deaths, and yet the oncology field is cruelly lacking tools to accurately predict and/or prevent metastasis. Distant metastasis occurs when circulating tumor cells interact with the endothelium of distant organs and extravasate from the blood vessel into the surrounding tissue. Selectins are a family of carbohydrate receptors well depicted for their role in tumor cells extravasation. They mediate primary interactions of cancer cells with endothelial cells, as well as secondary interactions with leucocytes and platelets, which are also promoting metastasis. The cancer associated carbohydrate antigen sialyl-Lewis x (sLex) has been repeatedly shown to be involved, as selectin ligand, in these interactions. However, recent studies have highlighted that glycosaminoglycans (GAGs), another class of glycans, may also serve as ligands for selectins. We report herein that cancer-associated GAGs are differentially recognized by selectins according to their density of sulfation and the pH conditions of the binding. We also show that these parameters regulate platelets-cancer cells heterotypic aggregation, supporting the idea that GAGs may have pro-metastatic function. Combining our experimental results with in depth analyses of molecular dockings, we propose a model of GAG/selectin interactions robust enough to recapitulate the differential binding of selectins to GAGs, the competition between GAGs and sLex for selectin binding and the effect of sub-physiological pH on GAGs affinities towards selectins. Altogether, our data suggest GAGs to be good ligands for selectins, potentially promoting distant metastasis in a complementary way to sLex.
Similar content being viewed by others
References
Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4(6):448–456
Läubli H, Borsig L (2010) Selectins promote tumor metastasis. Semin Cancer Biol 20(3):169–177
Cazet A, Julien S, Bobowski M, Burchell J, Delannoy P (2010) Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res 12(3):204
Haslam SM, Julien S, Burchell JM, Monk CR, Ceroni A, Garden OA, Dell A (2008) Characterizing the glycome of the mammalian immune system. Immunol Cell Biol 86(7):564–573
Barthel SR, Gavino JD, Wiese GK, Jaynes JM, Siddiqui J, Dimitroff CJ (2008) Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin. Glycobiology 18(10):806–817
Burdick MM, McCaffery JM, Kim YS, Bochner BS, Konstantopoulos K (2003) Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Physiol Cell Physiol 284(4):C977–C987
Julien S, Ivetic A, Grigoriadis A et al (2011) Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Cancer Res. doi:10.1158/0008-5472.CAN-11-1139
Varki A (1997) Selectin ligands: will the real ones please stand up? J Clin Invest 99(2):158–162
Monzavi-Karbassi B, Stanley JS, Hennings L, Jousheghany F, Artaud C, Shaaf S, Kieber-Emmons T (2007) Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer 120(6):1179–1191
Borsig L (2010) Antimetastatic activities of heparins and modified heparins Experimental evidence. Thromb Res 125(Suppl 2):S66–S71
Wang L, Brown JR, Varki A, Esko JD (2002) Heparin’s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 110(1):127–136
Weinhart M, Gröger D, Enders S, Riese SB, Dernedde J, Kainthan RK, Brooks DE, Haag R (2011) The role of dimension in multivalent binding events: structure-activity relationship of dendritic polyglycerol sulfate binding to L-selectin in correlation with size and surface charge density. Macromol Biosci 11(8):1088–1098
Malhotra R, Taylor NR, Bird MI (1996) Anionic phospholipids bind to L-selectin (but not E-selectin) at a site distinct from the carbohydrate-binding site. Biochem J 314(Pt 1):297–303
Barbareschi M, Maisonneuve P, Aldovini D et al (2003) High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer 98(3):474–483
Svensson KJ, Christianson HC, Kucharzewska P, Fagerström V, Lundstedt L, Borgquist S, Jirström K, Belting M (2011) Chondroitin sulfate expression predicts poor outcome in breast cancer. Int J Oncol 39(6):1421–1428
Barash U, Cohen-Kaplan V, Dowek I, Sanderson RD, Ilan N, Vlodavsky I (2010) Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis. FEBS J 277(19):3890–3903
Li J-P (2008) Heparin, heparan sulfate and heparanase in cancer: remedy for metastasis? Anticancer Agents Med Chem 8(1):64–76
Nadir Y, Brenner B (2009) Heparanase coagulation and cancer progression. Best Pract Res Clin Haematol 22(1):85–92
Sørlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869–10874
Cooney CA, Jousheghany F, Yao-Borengasser A et al (2011) Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Research 13(3):R58
Cesaretti M (2003) A 96-well assay for uronic acid carbazole reaction. Carbohydr Polym 54(1):59–61
Barbosa I (2003) Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology 13(9):647–653
Denys A, Allain F, Carpentier M, Spik G (1998) Involvement of two classes of binding sites in the interactions of cyclophilin B with peripheral blood T-lymphocytes. Biochem J 336(Pt 3):689–697
Deligny A, Denys A, Marcant A, Melchior A, Mazurier J, Van Kuppevelt TH, Allain F (2010) Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases. J Biol Chem 285(3):1701–1715
Halgren TA (1999) MMFF VI. MMFF94 s option for energy minimization studies. J Comput Chem 20(7):720–729
Gotte M, Spillmann D, Yip GW, Versteeg E, Echtermeyer FG, Van Kuppevelt TH, Kiesel L (2007) Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (ss4GalT-7) deficient form of Ehlers-Danlos syndrome. Hum Mol Genet 17(7):996–1009
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45
Van de Vijver MJ, He YD, Van’t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999–2009
Kawashima H, Hirose M, Hirose J, Nagakubo D, Plaas AH, Miyasaka M (2000) Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J Biol Chem 275(45):35448–35456
Hirose M, Matsumura R, Sato K, Murai T, Kawashima H (2011) Binding of L-selectin to its vascular and extravascular ligands is differentially regulated by pH. Biochem Biophys Res Commun 414(2):437–442
Coupland LA, Chong BH, Parish CR (2012) Platelets and p-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells. Cancer Res 72(18):4662–4671
Labelle M, Hynes RO (2012) The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. doi:10.1158/2159-8290.CD-12-0329
Somers WS, Tang J, Shaw GD, Camphausen RT (2000) Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell 103(3):467–479
Kawashima H, Atarashi K, Hirose M, Hirose J, Yamada S, Sugahara K, Miyasaka M (2002) Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J Biol Chem 277(15):12921–12930
Nelson RM, Cecconi O, Roberts WG, Aruffo A, Linhardt RJ, Bevilacqua MP (1993) Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood 82(11):3253–3258
Koenig A, Norgard-Sumnicht K, Linhardt R, Varki A (1998) Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest 101(4):877–889
Borsig L, Wang L, Cavalcante MCM, Cardilo-Reis L, Ferreira PL, Mourao PAS, Esko JD, Pavao MSG (2007) Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber: effect on tumor metastasis and neutrophil recruitment. J Biol Chem 282(20):14984–14991
Bachelet L, Bertholon I, Lavigne D, Vassy R, Jandrot-Perrus M, Chaubet F, Letourneur D (2009) Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets. Biochim Biophys Acta 1790(2):141–146
Matsumiya A, Yamaguchi M, Nakano H, Takeda M, Kumada K (1999) Dextran sulfate inhibits E-selectin-mediated neutrophil adhesion to endotoxin-activated vascular endothelial cells. Life Sci 64(2):PL9–17
Cecconi O, Nelson RM, Roberts WG, Hanasaki K, Mannori G, Schultz C, Ulich TR, Aruffo A, Bevilacqua MP (1994) Inositol polyanions. Noncarbohydrate inhibitors of L- and P-selectin that block inflammation. J Biol Chem 269(21):15060–15066
Poppe L, Brown GS, Philo JS, Nikrad PV, Shah BH (1997) Conformation of sLex Tetrasaccharide, Free in Solution and Bound to E-, P-, and L-Selectin. J Am Chem Soc 119:1727–1736
Gong L, Cai Y, Zhou X, Yang H (2012) Activated platelets interact with lung cancer cells through P-selectin glycoprotein ligand-1. Pathol Oncol Res 18(4):989–996
Matsui Y, Amano H, Ito Y et al (2012) Thromboxane A2 receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells. Cancer Sci 103(4):700–707
Lardner A (2001) The effects of extracellular pH on immune function. J Leukoc Biol 69(4):522–530
Nemoto EM, Frinak S (1981) Brain tissue pH after global brain ischemia and barbiturate loading in rats. Stroke 12(1):77–82
Habuchi O (2000) Diversity and functions of glycosaminoglycan sulfotransferases. Biochim Biophys Acta 1474(2):115–127
Acknowledgments
Authors would like to thank Pr. Christophe Biot and Pr. Xuefen Le Bourhis for fruitful scientific advising and proof-reading. This work was supported by CNRS and Université de Lille1. SJ is supported by the comité du Doubs de La Ligue contre le Cancer and the GEFLUC (Groupement des Entreprises Françaises pour la LUtte contre le Cancer), PD is supported by le comité de l’Aisne de La Ligue contre le Cancer and the Association pour la Recherche sur le Cancer (Grant n° 7936 and 5023).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Martinez, P., Vergoten, G., Colomb, F. et al. Over-sulfated glycosaminoglycans are alternative selectin ligands: insights into molecular interactions and possible role in breast cancer metastasis. Clin Exp Metastasis 30, 919–931 (2013). https://doi.org/10.1007/s10585-013-9592-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-013-9592-7